These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6977481)

  • 21. Surface membrane changes of T cells induced by syngeneic tumour cells. II. T-cell defects induced by small tumour cell inocula or tumour cell antigens.
    Chow DA; Paraskevas F; Dular U
    Int J Cancer; 1978 Nov; 22(5):621-9. PubMed ID: 309866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.
    Suzuki Y; Liu CM; Chen LP; Ben-Nathan D; Wheelock EF
    J Immunol; 1987 Nov; 139(9):3146-52. PubMed ID: 3117888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alanine inhibits cytotoxic responses: its production by different tumor cell lines explains differences in their immunogenicity.
    Dröge W; Wehrmaker A; Eck HP
    Cancer Detect Prev; 1988; 11(3-6):151-6. PubMed ID: 3134127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
    Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
    J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface membrane changes of T cells induced by syngeneic tumour cells. I. Formation and uptake of complexes of Ig and tumour antigens by T cells.
    Dular U; Chow DA; Paraskevas F
    Int J Cancer; 1978 Nov; 22(5):611-20. PubMed ID: 82542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
    Chow DA
    J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity as the predominant factor determining metastasis by murine lymphomas.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1979 Oct; 40(4):590-6. PubMed ID: 497109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth in vivo of l5178y-r murine leukaemic cells treated in vitro with cis-dichloro bis-(cyclopentylamine) platinum II.
    Szumiel I; Niepokojczycka E; Godlewska E
    Br J Cancer; 1981 Jan; 43(1):116-7. PubMed ID: 7459232
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression.
    Zhang ZY; Chow DA
    J Immunol; 1997 Jul; 159(1):344-50. PubMed ID: 9200472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to Rauscher virus-induced leukemia in DBA mice. II. Correlation between antigenic expression and pathogenesis.
    Tóth FD; Váczi L
    Neoplasma; 1978; 25(3):265-72. PubMed ID: 79984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Location of tumoral antigens in L5178Y murine lymphoma cells.
    Ramos-Damián ME; Gómez-Estrada H; Hernández-Delgado J; Tapia-Arizmendi L; Feria-Velasco A
    Arch Invest Med (Mex); 1980; 11(3):425-34. PubMed ID: 7469659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase of L5178Y lymphoma growth by means of placental antigen immunization.
    Bravo-Cuéllar A; Gomez-Estrada H; Ramos-Damián M
    Arch Invest Med (Mex); 1982; 13(3):191-4 passim. PubMed ID: 7125799
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of anti-lymphocyte and anti-thymocyte serum on the pathogenesis of Rauscher leukaemia in inbred mouse strains.
    Váczi L; Leövey A; Tóth FD; Kása M
    Acta Microbiol Acad Sci Hung; 1976; 23(4):309-16. PubMed ID: 1088332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antigenicity of ribosomal proteins from a malignant mouse cell line. Preliminary results].
    Ollier MP; Auger-Buendia MA; Hartmann L
    C R Seances Acad Sci D; 1979 Jul; 289(2):189-92. PubMed ID: 117923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera.
    Smith PJ; Robinson CM; Reif AE
    Cancer Res; 1974 Jan; 34(1):169-75. PubMed ID: 4129197
    [No Abstract]   [Full Text] [Related]  

  • 37. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
    Brown GW; Lesiuk TP; Chow DA
    J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of advanced aging on ability of mice to cause regression of an immunogenic lymphoma in response to immunotherapy based on depletion of suppressor T cells.
    Dunn PL; North RJ
    Cancer Immunol Immunother; 1991; 33(6):421-3. PubMed ID: 1878896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro.
    Gordon J; Murgita RA; Tomasi TB
    J Immunol; 1975 Jun; 114(6):1808-12. PubMed ID: 805179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.